AD/PD 2026

Congratulations to Cyril Helbling and Olga Sandoval who presented their latest research on diagnostics for neurodegenerative disorders at the 2026 International Conference on Alzheimer’s Disease and Parkinson’s Disease in Copenhagen, Denmark.

Cyril presented his progress on optimizing alpha-synuclein assays for accurate detection of Parkinson's and Lewy body pathology:

Design and validation of an alpha-synuclein seed amplification assay for Parkinson’s disease and dementia with Lewy bodies 

Cyril, Olga & Mari at ADPD 2026.

Olga presented multiple projects on diagnostics for Alzheimer's disease, leveraging the latest plasma biomarkers:

Use of plasma amyloid-beta 42 in addition to phospho-tau 217 increases the risk for pre-analytical error and may compromise diagnostic performance

Implementation considerations of pTau assays in patient care: A multi-platform comparison of diagnostic accuracy and analytical performance